- Home
- SVV vs MIRM Comparison
SVV vs MIRM Comparison
Compare SVV & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- MIRM
- Stock Information
- Founded
- SVV 1954
- MIRM 2018
- Country
- SVV United States
- MIRM United States
- Employees
- SVV N/A
- MIRM N/A
- Industry
- SVV Other Specialty Stores
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- MIRM Health Care
- Exchange
- SVV Nasdaq
- MIRM Nasdaq
- Market Cap
- SVV 1.7B
- MIRM 1.9B
- IPO Year
- SVV 2023
- MIRM 2019
- Fundamental
- Price
- SVV $9.13
- MIRM $44.73
- Analyst Decision
- SVV Buy
- MIRM Strong Buy
- Analyst Count
- SVV 5
- MIRM 13
- Target Price
- SVV $12.00
- MIRM $57.00
- AVG Volume (30 Days)
- SVV 907.7K
- MIRM 409.6K
- Earning Date
- SVV 11-07-2024
- MIRM 11-12-2024
- Dividend Yield
- SVV N/A
- MIRM N/A
- EPS Growth
- SVV 89.47
- MIRM N/A
- EPS
- SVV 0.44
- MIRM N/A
- Revenue
- SVV $1,518,397,000.00
- MIRM $307,028,000.00
- Revenue This Year
- SVV $3.58
- MIRM $73.07
- Revenue Next Year
- SVV $7.79
- MIRM $27.98
- P/E Ratio
- SVV $20.57
- MIRM N/A
- Revenue Growth
- SVV 2.30
- MIRM 112.14
- 52 Week Low
- SVV $7.78
- MIRM $23.14
- 52 Week High
- SVV $21.33
- MIRM $48.89
- Technical
- Relative Strength Index (RSI)
- SVV 42.33
- MIRM 61.50
- Support Level
- SVV $8.48
- MIRM $40.80
- Resistance Level
- SVV $10.05
- MIRM $44.12
- Average True Range (ATR)
- SVV 0.51
- MIRM 2.46
- MACD
- SVV -0.15
- MIRM 0.19
- Stochastic Oscillator
- SVV 24.71
- MIRM 61.23
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books and other goods from its non-profit partners ("NPPs"), either directly from them or via on-site donations ("OSDs") at Community Donation Centers at its stores. The company then process, selects, price, merchandise and sell these items in its stores.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.